Stock Events

Stock Events

TransCode Therapeutics (RNAZ) Q3 2024 Earnings

14AugConfirmed

Nov 22

Q4 2022

Q2 2024

Q3 2024

-0.74

-0.49

-0.25

0

Details

Expected EPS

-0.58

Actual EPS

-0.74

Surprise EPS

-0.16

Surprise Percent

+27.59%

Description

TransCode Therapeutics (RNAZ) has reported earnings of -0.74 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.